Cerebellar microglia-derived IL-17A mitigates autism-related behavioral and synaptic deficits

Authors:

Abstract
Interleukin-17 (IL-17) is a pleiotropic cytokine produced mainly by peripheral T helper 17 cells. Yet, the brain functions of IL-17 derived from central nervous cells remain poorly understood. Here, we find an aberrant IL-17A signaling in the cerebellum of Fmr1-KO mice, a well-established genetic model for autism spectrum disorder (ASD). Cerebellar IL-17A, derived exclusively from microglia, is essential for the regulation of social behaviors by maintaining neuronal excitability and selectively suppressing inhibitory neurotransmission of Purkinje cells (PCs) in the cerebellar Crus I, a brain region critically involved in social cognition. Specific downregulation of IL-17 receptor-mediated signaling in cerebellar PCs recapitulates ASD-like social deficits and repetitive behaviors. Notably, both direct administration of IL-17A and induction of IL-17A release from cerebellar microglia by poly(I:C) effectively restore PC excitability and ameliorate ASD-like symptoms. The findings uncover an indispensable role of microglia-derived IL-17A for cerebellar social processing and suggest potential therapeutic strategies targeting IL-17A signaling for ASD.
Funding Information
  • Ministry of Science and Technology of the People's Republic of China (STI2030-Major Projects-2021ZD0202805)
  • National Natural Science Foundation of China (32030044)
  • National Natural Science Foundation of China (32530049)
  • National Natural Science Foundation of China (32561160133)
  • National Natural Science Foundation of China (32200948)
  • National Natural Science Foundation of China (32450728)
  • National Natural Science Foundation of China (92468302)
  • National Natural Science Foundation of China (82522033)
  • National Natural Science Foundation of China (32171012)
  • Natural Science Foundation of Jiangsu Province (BK20190008)
  • Natural Science Foundation of Jiangsu Province (BK20240168)
  • State Key Laboratory of Pharmaceutical Biotechnology (LNSN-202402)
  • Natural Science Foundation of Beijing Municipality (F251014)
  • Chinese Institutes for Medical Research, Beijing